Document is current
Any future updates will be listed below
-
Authors
Xie, Fangyi https://orcid.org/0000-0001-5524-2750
Morken, Colleen M. https://orcid.org/0000-0001-8243-1960
Zhang, Nan https://orcid.org/0000-0002-0985-4227
Pittelkow, Mark R. https://orcid.org/0000-0001-7913-0294
Sartori Valinotti, Julio C. https://orcid.org/0000-0002-8965-5403
Comfere, Nneka I. https://orcid.org/0000-0002-8001-2639
Meves, Alexander https://orcid.org/0000-0001-7462-8288
Murphree, Dennis H. https://orcid.org/0000-0002-7800-455X
Mangold, Aaron R. https://orcid.org/0000-0001-6873-1705
Lehman, Julia S. https://orcid.org/0000-0002-7389-3853
,
-
Funding
Funding for this research was provided by:
British Association of Dermatologists (Geoffrey Dowling Fellowship)
The Appignani Lichen Planus Benefactor Gift
- License Information
-
More Information
Article History
Received: 11 July 2022
Revised: 9 January 2023
Accepted: 11 January 2023
First Online: 30 January 2023
Declarations
:
: A.R. Mangold is a principal investigator and consultant for Incyte and Eli Lilly.
: IRB approval status: Reviewed and approved by Mayo Clinic IRB; approval #21-007797.
